<DOC>
	<DOCNO>NCT00242697</DOCNO>
	<brief_summary>Use neuraxial agent anesthesia cardiac surgery expand . We use combined general-spinal anesthesia cardiac surgery 12 year . We hypothesize compare general anesthesia , combine technique would provide comparable intraoperative hemodynamics improve postoperative analgesia . This study subject technique double-blind randomized trial .</brief_summary>
	<brief_title>Double-Blind Comparison Combined General-Spinal Anesthesia General Anesthesia Coronary Artery Surgery</brief_title>
	<detailed_description>Use neuraxial agent anesthesia cardiac surgery expand . We use combined general-spinal anesthesia cardiac surgery 12 year . We perform trial order determine clinical impression technique would confirm . We hypothesize compare general anesthesia , combine technique would provide comparable intraoperative hemodynamics improve postoperative analgesia . This study subject technique double-blind randomized trial . METHODS After IRB approval , 63 consenting patient undergo non-emergent coronary artery bypass grafting ( CABG ) enter randomize , double-blind trial . Patients receive lorazepam 0.03 mg/kg preoperatively , midazolam 0.03 mg/kg line insertion induction . Spinal procedure , perform unblinded study anesthesiologist , precede general anesthesia , induce propofol rocuronium , maintain isoflurane CPB , propofol thereafter . All caregiver blind group assignment . Opioid spinal management define 3 group : GA : Sufentanil IV : 3 μg/kg induction , 1 μg/kg x 2 prn ; mock spinal SO : Sufentanil IV : 0.2 μg/kg induction , 0.1 μg/kg x 2 prn ; Spinal : sufentanil 50 μg , morphine 0.5 mg , hyperbaric SL : Sufentanil IV : 0.2 μg/kg induction , 0.1 μg/kg x 2 prn ; Spinal : sufentanil 25 μg , morphine 0.5 mg , bupivacaine 9.75 mg , hyperbaric When patient stable ICU , propofol stop extubation protocol begin . Patients receive schedule NSAID prn opioid , IV PO . The chi-square test ANOVA use Scheffe method multiple comparison apply appropriately . The primary end point study analgesic requirement , visual analogue pain score , duration endotracheal intubation intensive care unit . Secondary endpoint intraoperative hemodynamic variable , blood catecholamine lactate level , anesthetic supplementation , vasoactive drug support .</detailed_description>
	<mesh_term>Coronary Artery Disease</mesh_term>
	<mesh_term>Myocardial Ischemia</mesh_term>
	<mesh_term>Coronary Disease</mesh_term>
	<mesh_term>Anesthetics</mesh_term>
	<criteria>patient undergoing nonemergent primary coronary artery bypass graft use cardiopulmonary bypass &lt; 25 &gt; 80 year age leave ventricular ejection fraction &lt; 35 % receive inotropic intraaortic balloon therapy time surgery receive intravenous heparin therapy time surgery preexist back problem lumbar area clinical laboratory evidence coagulopathy</criteria>
	<gender>All</gender>
	<minimum_age>25 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>October 2005</verification_date>
	<keyword>coronary artery bypass surgery</keyword>
	<keyword>anesthesia , general</keyword>
	<keyword>anesthesia , spinal</keyword>
	<keyword>heart-lung machine</keyword>
</DOC>